![HeartFlow](http://media.vumedi.com/thumbs/channel_logo/2023/3/09a587b4-650f-4ee8-8428-324db99d1cb4.png.200x0_q85.png)
HeartFlow
Bringing together human ingenuity and advanced technology to help combat heart disease, the #1 cause of death.
HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary arteries, enabling physicians to create more effective treatment plans for their patients.
At the heart of our mission is a commitment to making cardiovascular care easier for doctors and safer for patients. Physicians get the critical information they need without the added risks and costs of an invasive procedure.
Follow us on Twitter @HeartFlow
Follow us on LinkedIn HeartFlow, Inc.
Visit our website at www.heartflow.com
The importance of lesion-specific FFRCT values in the non-invasive assessment of coronary artery disease
Three leading experts discuss:
- Lessons learned from 10 years of FFRCT Interpretation Mark Rabbat, MD, FSCCT, FACC, FAHA – Cardiologist in Chicago, IL
- Moving beyond a binary value: exploring translesional pressure loss with FFRCT Jonathon Leipsic, MD, FRCPC, MSCCT – Radiologist in Vancouver, BC
- How lesion-specific physiology informs treatment in the cath lab Colin Barker, MD, FACC, FSCAI – Interventional Cardiologist in Nashville, TN
Login to view comments.
Click here to Login
Videos